Litcius/Paper detail

Paradigm shift of “classical” HDAC inhibitors to “hybrid” HDAC inhibitors in therapeutic interventions

Gargi Nikhil Vaidya, Pooja Rana, Ashwini Venkatesh, Deep Rohan Chatterjee, Darshan Contractor, Dinesh Parshuram Satpute, Mithilesh Nagpure, Alok Jain, Dinesh Kumar

2020European Journal of Medicinal Chemistry46 citationsDOIOpen Access PDF

Topics & Concepts

PharmacophoreHistone deacetylasePharmacologyDrugEpigeneticsComputational biologyBioinformaticsChemistryMedicineHistoneGeneBiologyBiochemistryHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsPeptidase Inhibition and Analysis
Paradigm shift of “classical” HDAC inhibitors to “hybrid” HDAC inhibitors in therapeutic interventions | Litcius